Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Fournel

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophilsYoan Velut, Elise Decroix, Hélène Blons, et al.
Cancers|February 27, 2026
Validation of the 9th Edition of the TNM Classification in Patients with NSCLC and Lymph Node Involvement: A Retrospective, Multicentric, Observational StudyCarolina Sassorossi, Marco Chiappetta, Filippo Lococo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2019
Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung TumorsAudrey Mansuet-Lupo, Marc Barritault, Marco Alifano, et al.
ERJ Open Research|December 10, 2025
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia associated with lung adenocarcinoma: clinical, pathological and oncological outcomes from a multicentre analysisMaria Teresa Congedo, Dania Nachira, Alessandra Cancellieri, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 26, 2025
The outcomes of salvage surgery for non-small cell lung cancer after immune checkpoint inhibitor or targeted therapy treatment. A multi-center international real-life studyFrancesco Guerrera, Filippo Lococo, Ludovic Fournel, et al.
Journal for Immunotherapy of Cancer|October 17, 2020
Natural killer cells in the human lung tumor microenvironment display immune inhibitory functionsJules Russick, Pierre-Emmanuel Joubert, Mélanie Gillard-Bocquet, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2018
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 BlockadeJérôme Biton, Hanane Ouakrim, Agnès Dechartres, et al.
Plos One|January 14, 2021
Impact of integrating objective structured clinical examination into academic student assessment: Large-scale experience in a French medical schoolAlexandre Matet, Ludovic Fournel, François Gaillard, et al.
Cancer Discovery|August 5, 2025
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T cellular therapySimon Baldacci, Elliott J Brea, Francesco Facchinetti, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|May 21, 2022
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophilsYoan Velut, Elise Decroix, Hélène Blons, et al.
Cancers|February 27, 2026
Validation of the 9th Edition of the TNM Classification in Patients with NSCLC and Lymph Node Involvement: A Retrospective, Multicentric, Observational StudyCarolina Sassorossi, Marco Chiappetta, Filippo Lococo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2019
Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung TumorsAudrey Mansuet-Lupo, Marc Barritault, Marco Alifano, et al.
ERJ Open Research|December 10, 2025
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia associated with lung adenocarcinoma: clinical, pathological and oncological outcomes from a multicentre analysisMaria Teresa Congedo, Dania Nachira, Alessandra Cancellieri, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 25, 2019
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patientsAnne Jouinot, Guillaume Ulmann, Clara Vazeille, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 26, 2025
The outcomes of salvage surgery for non-small cell lung cancer after immune checkpoint inhibitor or targeted therapy treatment. A multi-center international real-life studyFrancesco Guerrera, Filippo Lococo, Ludovic Fournel, et al.
Journal for Immunotherapy of Cancer|October 17, 2020
Natural killer cells in the human lung tumor microenvironment display immune inhibitory functionsJules Russick, Pierre-Emmanuel Joubert, Mélanie Gillard-Bocquet, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2018
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 BlockadeJérôme Biton, Hanane Ouakrim, Agnès Dechartres, et al.
Plos One|January 14, 2021
Impact of integrating objective structured clinical examination into academic student assessment: Large-scale experience in a French medical schoolAlexandre Matet, Ludovic Fournel, François Gaillard, et al.
Cancer Discovery|August 5, 2025
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T cellular therapySimon Baldacci, Elliott J Brea, Francesco Facchinetti, et al.
Pageof 8